Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Macter InternationalKAR:MACTER +0.41%11 Receivables Turnover is 0.00 as of . 20. GuruFocus rates KAR:MACTER with a GF Score™ of 11/100. The stock has 1 warning sign investors should review. Among 950 Drug Manufacturers companies, Macter International ranks worse than 105263.05% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Macter International's Revenue for the
six
months ended in . 20 was ₨0.00 Mil. Macter International's average Accounts Receivable for the
six
months ended in . 20 was ₨0.00 Mil.
Macter International (KAR:MACTER) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Macter International Receivables Turnover Related Terms
Macter International Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Macter International's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Macter International Receivables Turnover Chart
Macter International Annual Data
Trend
Receivables Turnover
Macter International Semi-Annual Data
Receivables Turnover
KAR:MACTER vs ZTS, UTHR, VTRS: Receivables Turnover Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Macter International's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Macter International Receivables Turnover vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Macter International's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Macter International's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Macter International (KAR:MACTER) has a Receivables Turnover of 0.00 as of . 20. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Macter International and its competitors. According to the industry distribution chart, Macter International ranks #999999 out of 950 companies in the Drug Manufacturers industry.
Is Macter International's Receivables Turnover too high?
Macter International's current Receivables Turnover is 0.00. Based on the distribution chart, Macter International ranks #999999 out of 950 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Macter International has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Macter International's Receivables Turnover compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Macter International ranks #999999 out of 950 companies for Receivables Turnover. This places Macter International in the lower half of its industry. The industry median Receivables Turnover is 5.07. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Drug Manufacturers company?
The median Receivables Turnover among Drug Manufacturers companies is 5.07, based on 950 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Macter International and its competitors. For the Drug Manufacturers industry, the median Receivables Turnover is 5.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Macter International's current Receivables Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Macter International stock overvalued right now?
Macter International (KAR:MACTER) has a current Receivables Turnover of 0.00. The current Receivables Turnover is 0.00. Macter International's overall GF Score™ is 11/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Macter International (KAR:MACTER), the current Receivables Turnover is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Macter International Ltd is engaged in the manufacturing and marketing of pharmaceutical products and formulations for healthcare companies in Pakistan. It is covering almost all therapeutic categories including Antibiotics, Anti-allergy, cardiovascular, Anti-viral, and many more.
11GF Score
Get the complete analysis for KAR:MACTER
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KAR:MACTER has been successfully added to your 
